In our previous study it was described that the large dose of triiodo-l-thyronine (T3) or thyroxine (T4), when administered to the mice prepared for McKenzie bioassay reduced the thyroidal responsiveness to TSH or LATS as evidenced by the decrease in thyroidal intracellular colloid droplet formation and subsequent radioiodine release (Shishiba, et al., 1974) . To clarify the possible site of action of thyroid hormone itself on thyroid tissue, an in vitro extention of the study was required because precise comparison of the responsiveness of thyroid tissue to those reagents was possible at a fixed concentration of TSH or other stimulators.
For the mechanism of thyroid secretion, it was postulated that TSH stimulates adenylate cyclase activity to increase cyclic AMP levels in the thyroid tissue, the latter being responsible for the stimulation of intracellular colloid droplet formation resulting in the subsequent hormonal release (Pastan and Wollman, 1967) . Taking this postulate into account, in the present study, we sought to determine whether the effect of T3 exists at the site where TSH increases cyclic AMP levels or at the site where increased cyclic AMP enhances the formation of intracellular colloid droplet.
Materials and Methods
The methods employed were almost the same as described by Williams and Wolff with slight modification for laboratory adoption . The male mice of ddy atrain, purchased at the age of four weeks and kept on low iodine diet for two weeks, were employed all through the experiments.
The mice were sacrificed with the dislocation of the neck. (Steiner, et al., 1969 Figure 1 shows the results of the experiment in which effect of concentration of TSH on the number of intracellular colloid droplets in thyroid tissue in vitro. As noted in the figure, TSH, even at the concentration of 0.005mU/ml was effective in inducing a significant rise in intracellular colloid droplets.
The effect was plateaued at the concentration of TSH ranging from 0.1 mU/ ml to 2.5mU/ml, and then, decreased at the higher concentration of TSH. Table 1 summarizes the results of the experiment in which the effect of T3, iodide or tyrosine on the intracellular colloid droplet formation in vitro.
As shown, TSH induced intracellular colloid droplets. to the level as much as 734. T3 or iodide, when tested at the cencenration of 10-4M or less, did not show any significant effect.. When the dose of T3 or iodide increased to 10-3M, however, significant inhibition of TSH-induced colloid droplet formation was obvious as evidenced by the decrease in the number of colloid droplet to the level approximately half of the control. This inhibitory effect of T3 or iodide on colloid droplet formation was manifest not only at the dose of TSH 0.1mU, but also at 3.3mU/ml as shown in Table 2 and 3. Tyrosine, even at the concentration of 10-3 M, was not effective at all in this aspect. Table 2 summarizes the results of the expriment in which the effect of T3 or iodide on the response of thyloid tissue either to TSH or DBC-AMP. In the former, tissue levels of cyclic AMP were concomitantly measured with the colloid droplet formation. When TSH (3.3 mU/ml) was added to the medium, intracellular colloid droplets were listed on the table. Significance of the difference between 2) and 4) for colloid droplet study with TSH is p <0.01. The statistical analysis for cyclic AMP between no stimulator and TSH-group is highly significant (p <0.01) by the paired t test for the line 1), 2), 3) and 4).
increased to the magnitude as much as 989. Concurrently, cyclic AMP of the tissue was increased from 0.26pM/mg to the level of 1.37 pM/mg. T3, although ineffective in influencing either colloid droplet formation or cyclic AMP levels by itself, inhibited the TSH-induced rise in colloid droplet counts to 146. Cyclic AMP levels in the tissue, however, were normally increased by TSH even in the presence of T3. Iodide, at the concentration of 10-3M, inhibited TSH-induced colloid droplet formation in a fashion similar to T3. In the presence of iodide, TSH-induced increase in cyclic AMP was less although the difference from that without the addition of iodide was slightly short of statistical significance. While inhibited by iodide, the increase in cyclic AMP induced by TSH was still significant when compared to the basal level (P <0.01).
Although not shown here, the effect of T3 or iodide in this aspect was reversible when T3 or iodide was washed out from the medium.
When DBC-AMP, instead of TSH, was added to the medium, the colloid droplet formation was increased to the level of 950. Both T3 and iodide inhibited the DBC-AMP-induced colloid droplet formation to the level significantly different from the. response elicited by DBC-AMP only. 
Discussion
The present study demonstrates that T3 or iodide, at the concentration of 10-3M, inhibits TSH-induced intracellular colloid droplet formation, while those reagents were not effective in inhibiting the concurrent rise in cyclic AMP levels in the tissue. To further confirm the possible site of the action of T3 or iodide, the effects of T3 or iodide on DBC-AMP-induced colloid droplet formation was also studied.
From the current concepts, TSH stimulates adenylate cyclase activity resulting in an increase in cyclic AMP levels in thyroid tissue, the latter being responsible for an increase in intracellular colloid droplet formation (Pastan and Wollman, 1967) . Based on this postulate, it was argued that, if inhibiton of colloid droplet formation was due to inhibition of adenylate cyclase, T3 or iodide should inhibit only the TSH-but not DBC-AMP-induced colloid droplet formation. Our experiments show that T3 or iodide also inhibits DBC-AMP-induced increase incolloid droplet formrtion.
The present results, thus, demonstrate that an inhibitory locus for T3 or iodide exists at a droplet formation.
Finally, the present result obtained in vitro does not necessarily mean that the effect of T3 or iodide in vivo is also at the point beyond cyclic AMP generation and prior to colloid droplet formation.
In our in vivo study, thyroid hormone administered in vivo, reduced the cyclic AMP generation and colloid droplet formation induced by TSH in vitro (Shishiba, et al., 1974b) .
For the explanation of this discrepancy, it would be argued that a physiological site of T3 action may be deranged in the artificial in vitro condition and the site which is not manifest in vivo may be revealed, as stated by Oppenheimer (Oppenheimer, et al, 1973) . Another in vivo counterpart of the present study is the report by Ohtake et al informing the temporal inhibition of colloid droplet formation induced by TSH in vivo (Ohtake, et al., 1973 ). The precise relevancy of the present experiment to their observation remains to be disclosed.
